DE69226931T2 - Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten - Google Patents

Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten

Info

Publication number
DE69226931T2
DE69226931T2 DE69226931T DE69226931T DE69226931T2 DE 69226931 T2 DE69226931 T2 DE 69226931T2 DE 69226931 T DE69226931 T DE 69226931T DE 69226931 T DE69226931 T DE 69226931T DE 69226931 T2 DE69226931 T2 DE 69226931T2
Authority
DE
Germany
Prior art keywords
receptor antagonists
suitable substituent
carbamimidoyl
hydrogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69226931T
Other languages
English (en)
Other versions
DE69226931D1 (de
Inventor
Yousuke Katsura
Tetsuo Tomishi
Yoshikazu Inoue
Hisashi Takasugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69226931D1 publication Critical patent/DE69226931D1/de
Publication of DE69226931T2 publication Critical patent/DE69226931T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69226931T 1991-12-06 1992-12-02 Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten Expired - Fee Related DE69226931T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125970A GB9125970D0 (en) 1991-12-06 1991-12-06 New compounds

Publications (2)

Publication Number Publication Date
DE69226931D1 DE69226931D1 (de) 1998-10-15
DE69226931T2 true DE69226931T2 (de) 1999-03-18

Family

ID=10705819

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69226931T Expired - Fee Related DE69226931T2 (de) 1991-12-06 1992-12-02 Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten

Country Status (14)

Country Link
US (1) US5532258A (de)
EP (1) EP0545376B1 (de)
JP (1) JP2531329B2 (de)
CN (1) CN1079469A (de)
AT (1) ATE170851T1 (de)
AU (1) AU666893B2 (de)
CA (1) CA2084640A1 (de)
DE (1) DE69226931T2 (de)
GB (1) GB9125970D0 (de)
HU (3) HU9203849D0 (de)
IL (1) IL103826A0 (de)
MX (1) MX9206930A (de)
TW (1) TW211565B (de)
ZA (1) ZA928876B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427539A1 (de) * 1994-08-04 1996-02-08 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung von 2-Cyaniminothiazolidin
GB9416459D0 (en) * 1994-08-15 1994-10-05 Fujisawa Pharmaceutical Co New compounds
ATE227279T1 (de) * 1995-12-29 2002-11-15 Boehringer Ingelheim Pharma Phenyl thiazol derivate mit antiherpesvirus eigenschaften
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
DE19719053A1 (de) * 1997-05-06 1998-11-12 Bayer Ag Substituierte Aminothiazole
US6100282A (en) 1998-01-02 2000-08-08 Hoffman-La Roche Inc. Thiazole derivatives
AU2002357137A1 (en) * 2001-12-10 2003-06-23 Bristol-Myers Squibb Company (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
DE102004008141A1 (de) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003640B1 (de) * 1978-01-18 1982-01-27 Imperial Chemical Industries Plc Antisekretorische Guanidinderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
IT1200371B (it) * 1982-03-24 1989-01-18 Angeli Inst Spa Guanidino eterociclifenilamidine,processi per la loro preparazione e loro impiego farmaceutico
US4452985A (en) * 1983-02-14 1984-06-05 American Home Products Corporation 2-Guanyl-4-(substituted phenyl) thiazole derivatives

Also Published As

Publication number Publication date
ATE170851T1 (de) 1998-09-15
GB9125970D0 (en) 1992-02-05
TW211565B (de) 1993-08-21
US5532258A (en) 1996-07-02
CN1079469A (zh) 1993-12-15
CA2084640A1 (en) 1993-06-07
EP0545376B1 (de) 1998-09-09
JPH06321921A (ja) 1994-11-22
MX9206930A (es) 1993-06-01
DE69226931D1 (de) 1998-10-15
AU666893B2 (en) 1996-02-29
JP2531329B2 (ja) 1996-09-04
EP0545376A1 (de) 1993-06-09
HU211604A9 (en) 1995-12-28
AU2983792A (en) 1993-06-10
HUT65776A (en) 1994-07-28
HU9203849D0 (en) 1993-03-29
IL103826A0 (en) 1993-04-04
ZA928876B (en) 1993-07-15

Similar Documents

Publication Publication Date Title
MX9306831A (es) Nuevos compuestos heterociclicos.
NO940737L (de)
DE69431974D1 (de) Benzamid-Derivate und ihre Verwendung als Vasopressin-Antagonisten
ES2095833T3 (es) Derivados de benzodiazepinas.
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
FI890689A (fi) 3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
DK0622361T3 (da) Heterocykliske forbindelser som bradykininantagonister
PE20011348A1 (es) Agentes antivirales de imidazopiridina e imidazopimiridina
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
DE69226931D1 (de) Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten
ES2093091T3 (es) Derivado de glutation.
DK0420121T3 (da) Antitumormiddel
DE69415314D1 (de) Neue bisoxadiazolidinderivate
CA2118425A1 (en) Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof
DE69001004T2 (de) Zusammensetzung gegen leberkrankheiten.
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
TW275629B (de)
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee